首页> 美国卫生研究院文献>Diagnostics >Ultrasonographic Diagnosis of Placenta Accreta Spectrum (PAS) Disorder: Ideation of an Ultrasonographic Score and Correlation with Surgical and Neonatal Outcomes
【2h】

Ultrasonographic Diagnosis of Placenta Accreta Spectrum (PAS) Disorder: Ideation of an Ultrasonographic Score and Correlation with Surgical and Neonatal Outcomes

机译:超声诊断胎盘ACCRETA谱(PAS)紊乱:超声评分的思想和外科和新生儿结果的相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to evaluate a novel ultrasonographic scoring system for the diagnosis of PAS and the prediction of maternal and neonatal outcomes. In this retrospective study, 138 patients with at least one previous caesarean section (CS) and placenta previa were included. They were divided into four groups ranging from Group 0 (Non PAS) to Group 3 (Placenta Percreta) according to the histological or surgical confirmation. Their ultrasound examinations during pregnancy were reviewed according to the nine different ultrasound signs reported by the European Working Group on Abnormally Invasive Placenta. For each parameter, 0 to 2 points were assigned. The sum of the points reflects the severity of PAS with a maximum score of 20. The scoring system revealed good performances in evaluation metrics, with an overall accuracy of 94%. In addition to this, patients’ characteristics and surgical and neonatal outcomes were analyzed with an evidence of higher incidence of complications in severe forms. Our study suggests that antenatal ultrasonographic diagnosis of PAS is feasible with sufficient level of accuracy. This will be important in identifying high-risk patients and implementing preventive strategy.
机译:本研究的目的是评估一种用于诊断PAS和母亲和新生儿结果的预测的新型超声评分系统。在这项回顾性研究中,包括138名患有以前的先前剖腹产(CS)和PREVIA的患者。根据组织学或手术确认,将它们分为从第0组(非PAS)(非PAS)到第3组(胎盘PERCRETA)。根据欧洲工作组在异常侵入性的胎盘上报告的九个不同超声标志进行了妊娠期间的超声检查。对于每个参数,分配0到2个点。该点的总和反映了PA的最大得分为20。评分系统揭示了评估度量的良好表现,总精度为94%。除此之外,患者的特征和外科和新生儿结果是分析的,证据表明严重形式的并发症发病率较高。我们的研究表明,PAS的产前超声诊断是可行的,具有足够的精度水平。这对于识别高风险患者和实施预防策略将是重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号